Interactions between anti-infective agents and immunosuppressants-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Clinical Transplantation
Tracy SparkesAST Infectious Diseases Community of Practice

Abstract

These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation provide an update on potential drug-drug interactions between anti-infectives and immunosuppressants, which are most notable with calcineurin and mTOR inhibitors. Drug-drug interactions may occur through pharmacokinetic mechanisms leading to altered drug concentrations of either the anti-infective or immunosuppressive drug, or by pharmacodynamic interactions increasing or decreasing the efficacy or toxicity of the medications. Many of the significant pharmacokinetic interactions occur through inhibition or induction of the cytochrome 3A4 system by anti-infective agents leading to increased or decreased immunosuppressive agent levels, respectively. The membrane transporter P-glycoprotein is also often involved in drug interactions. Since the last iteration of these guidelines, multiple new hepatitis C virus direct-acting antivirals have become available for use in SOT recipients. Of these agents, some are substrates of cytochrome and drug transporter systems, while others inhibit these systems and may affect immunosuppressive agents. Due to the high risk for drug-drug interactions in the solid organ transplant p...Continue Reading

References

Aug 1, 1992·Clinical Pharmacokinetics·P PeritiA Novelli
May 11, 1991·Clinical Pharmacology and Therapeutics·S K YamashitaW J Jusko
Aug 15, 1990·Annals of Internal Medicine·M R KramerJ Theodore
Dec 5, 1987·Lancet·D TrenkD Birnbaum
Oct 1, 1987·Clinical Pharmacology and Therapeutics·R J KandrotasW J Jusko
Jun 1, 1986·Clinical Pharmacology and Therapeutics·A M GlynnW J Jusko
May 1, 1983·British Journal of Haematology·J M HowsE C Gordon-Smith
Jul 11, 1994·Archives of Internal Medicine·F CarrieB Becq-Giraudon
Dec 5, 1998·Clinical Pharmacokinetics·J H Lin, A Y Lu
Feb 11, 2000·The Annals of Pharmacotherapy·R Y ChenhsuW C Yang
Jun 15, 2000·European Journal of Clinical Pharmacology·T VarisP J Neuvonen
Mar 27, 2001·Transplantation Proceedings·R BanerjeeN R Banner
May 23, 2002·The Annals of Pharmacotherapy·John M KovarikChristiane Rordorf
Jun 13, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shahid Husain, Nina Singh
Aug 23, 2002·Clinical Pharmacokinetics·Uwe ChristiansAlfonso Lampen
May 14, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Kenneth BachmannKamlesh Thakker
Feb 18, 2004·Transplantation·Paulose P ThomasChakko K Jacob
Sep 24, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Aurora López-MontesCarmen Gómez
Jan 13, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Titte R SrinivasBruce Kaplan
Feb 3, 2005·Transplantation Proceedings·B SádabaJ R Azanza
Mar 24, 2005·Transplantation·Dirk R KuypersKoenraad Desmet
Sep 22, 2005·Therapeutic Drug Monitoring·Eva M VasquezEnrico Benedetti
Dec 21, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·David ShitritMordechai R Kramer
Jun 29, 2006·American Journal of Nephrology·Khalid Farouk El-DahshanMohamed Abdel-Kader Sobh
Nov 10, 2006·The New England Journal of Medicine·Daniel C BrennanUNKNOWN Thymoglobulin Induction Study Group
Jun 5, 2007·Pharmacotherapy·Angela Sansone-ParsonsTim G Mant
Oct 24, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·L A FrassettoL Z Benet
Sep 25, 2008·The Annals of Pharmacotherapy·Federico PeaPierluigi Viale
Nov 26, 2008·Clinical Pharmacokinetics·Yasmine NivoixGenevieve Ubeaud-Sequier

❮ Previous
Next ❯

Citations

Mar 14, 2020·AIDS·Rebecca N Kumar, Valentina Stosor
Jan 12, 2021·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Saranya ThitisuriyaraxKamonwan Jutivorakool
Feb 5, 2021·Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation·Reem S AlmaghrabiAli S Omrani
May 6, 2021·Journal of Fungi·William Alegria, Payal K Patel
May 25, 2021·Seminars in Respiratory and Critical Care Medicine·Daniel Z P Friedman, Karen Doucette
Oct 9, 2021·Current Opinion in Organ Transplantation·Courtney E Harris, Nicolas C Issa
Nov 11, 2021·Pharmacology Research & Perspectives·Ana Isabel Gago-SánchezMiguel Ángel Calleja

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Transplantation
Emily A BlumbergAmerican Society of Transplantation Infectious Diseases Community of Practice
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Jennifer Trofe-ClarkAST Infectious Diseases Community of Practice
© 2022 Meta ULC. All rights reserved